2022年第20届国际内分泌大会(ICE)/2022年第18届亚洲-大洋洲内分泌学大会(AOCE)/2022年第21届东盟内分泌学会联合会(AFES)

2022年第20届国际内分泌学大会(ICE 2022)暨第18届亚洲-大洋洲内分泌学大会(AOCE)、第21届东盟内分泌学会联合会(AFES)将于2022年8月25日至29日在新加坡举行，会议由国际内分泌学会(ISE)、新加坡内分泌学与代谢学会(EMSS)联合组织，预计有来自世界各地的5000余名专业人士与会。

国际内分泌学会(ISE)是由全球内分泌组织组成的国际社群，自1960年成立以来一直致力于在全球范围内促进内分泌学的教育、科学和患者护理的进步。如今ISE成为一个整合了内分泌和代谢学所有领域的全球网络，成员包括70多个国家的内分泌学会，代表全球近50000名内分泌学家；ISE联合全球内分泌学界，促进会员组织和利益相关者之间的国际合作；ISE在全球范围内提供教育；ISE提供一个平台以协调全球内分泌组织与医疗保健专业人员之间的科学交流、教育和伙伴关系；ISE关注支持世界各地早期职业内分泌学家，支持发展中国家和地区的内分泌学网络。ISE与其成员合作组织国际内分泌学大会(ICE)，每两年在世界不同地区举行一次，ICE是传播内分泌学广泛领域最新发展的主要渠道。

20th International Congress of Endocrinology (ICE 2022)
18th Asia-Oceania Congress of Endocrinology (AOCE 2022)
21st ASEAN Federation of Endocrine Societies Congress (AFES 2022)

Date: August 25-28, 2022 2022、
Location: Singapore, Singapore

摘要征集：

• Abstract Submission Opens: 1 Jan 2022
• Abstract Submission Closes: 30 Apr 2022
• Early Bird Fee Closes: 30 Apr 2022
• Notice of Abstracts Acceptance: 31 May 2022

点此提交摘要>>>Submit Abstract>>>

Themes

Abstract Submission Terms & Conditions

• All abstracts must be submitted in English. 
• Only online submissions are accepted. Other forms of submission will not be considered. 
• Abstracts should contain original material that has neither been published nor presented at another International meeting at the time of submission. In addition, abstracts should not be submitted to international meetings which take place before ICE 2022. However, abstracts submitted to, or presented at, local and national meetings will be considered. If applicable, the abstract should state: "This research has been approved by an ethical committee". 
• Since all abstracts accepted for oral or poster presentation will be published, they should be of copy-proof quality. 
• Please refer to Abstract Submission Page for Acceptance Notification. 
• Presenting authors are required to register for the congress if the paper is accepted. If the registration fee of the presenting author is not received by the given deadline, his / her paper will be considered as being withdrawn.

会议对象: 医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。